10-Q Filing

Astrana Health, Inc. CIK: 1083446 Q1 2019

Filing Information

Form Type	10-Q
Accession Number	`0001144204-19-025049`
Period End Date	20190331
Filing Date	20190510
Fiscal Year	2019
Fiscal Period	Q1
XBRL Instance	ameh-20190331.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 97 Income Statement 42 Cash Flow Statement 91 Stockholders Equity 18

Balance Sheet 97 line items

Line Item	Tag	Value	Unit	Period
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$103.73M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$93.01M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$106.89M	USD	Point-in-time
Investment in marketable securities	`MarketableSecuritiesCurrent`	$1.14M	USD	Point-in-time
Investment in marketable securities	`MarketableSecuritiesCurrent`	$1.13M	USD	Point-in-time
Receivables, net	`AccountsReceivableNetCurrent`	$7.13M	USD	Point-in-time
Common Stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common Stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Receivables, net	`AccountsReceivableNetCurrent`	$6.64M	USD	Point-in-time
Receivables, net related parties	`DueFromRelatedPartiesCurrent`	$49.33M	USD	Point-in-time
Common Stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Receivables, net related parties	`DueFromRelatedPartiesCurrent`	$55.89M	USD	Point-in-time
Common Stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Other receivables	`OtherReceivablesNetCurrent`	$1.00M	USD	Point-in-time
Common Stock, shares outstanding	`CommonStockSharesOutstanding`	34.58M	shares	Point-in-time
Common Stock, shares outstanding	`CommonStockSharesOutstanding`	34.50M	shares	Point-in-time
Other receivables	`OtherReceivablesNetCurrent`	$12.25M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$7.98M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$7.39M	USD	Point-in-time
Treasury Stock, Common, Shares	`TreasuryStockCommonShares`	1.94M	shares	Point-in-time
Treasury Stock, Common, Shares	`TreasuryStockCommonShares`	1.85M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$176.91M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$172.86M	USD	Point-in-time
Land, property and equipment, net	`PropertyPlantAndEquipmentNet`	$12.72M	USD	Point-in-time
Land, property and equipment, net	`PropertyPlantAndEquipmentNet`	$12.33M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$86.88M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$83.06M	USD	Point-in-time
Goodwill	`Goodwill`	$185.81M	USD	Point-in-time
Goodwill	`Goodwill`	$185.81M	USD	Point-in-time
Loans receivable related parties	`DueFromRelatedPartiesNoncurrent`	$17.50M	USD	Point-in-time
Loans receivable related parties	`DueFromRelatedPartiesNoncurrent`	$17.50M	USD	Point-in-time
Investments in other entities equity method	`EquityMethodInvestments`	$34.03M	USD	Point-in-time
Investments in other entities equity method	`EquityMethodInvestments`	$34.88M	USD	Point-in-time
Investment in a privately held entity that does not report net asset value per share	`InvestmentInPrivatelyHeldEntityThatDoesNotReportNetAssetValuePerShare`	$405.00K	USD	Point-in-time
Investment in a privately held entity that does not report net asset value per share	`InvestmentInPrivatelyHeldEntityThatDoesNotReportNetAssetValuePerShare`	$405.00K	USD	Point-in-time
Restricted cash	`RestrictedCashNoncurrent`	$745.29K	USD	Point-in-time
Restricted cash	`RestrictedCashNoncurrent`	$740.21K	USD	Point-in-time
Restricted cash	`RestrictedCashNoncurrent`	$745.47K	USD	Point-in-time
Right-of-use assets	`OperatingLeaseRightOfUseAsset`	-	USD	Point-in-time
Right-of-use assets	`OperatingLeaseRightOfUseAsset`	$8.53M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$1.55M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$1.21M	USD	Point-in-time
Total noncurrent assets	`AssetsNoncurrent`	$343.95M	USD	Point-in-time
Total noncurrent assets	`AssetsNoncurrent`	$340.14M	USD	Point-in-time
Total assets	`Assets`	$513.00M	USD	Point-in-time
Total assets	`Assets`	$520.86M	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$47.65M	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$25.08M	USD	Point-in-time
Fiduciary accounts payable	`FiduciaryAccountsPayableCurrent`	$2.08M	USD	Point-in-time
Fiduciary accounts payable	`FiduciaryAccountsPayableCurrent`	$1.54M	USD	Point-in-time
Medical liabilities	`MedicalLiabilitiesCurrent`	$33.64M	USD	Point-in-time
Medical liabilities	`MedicalLiabilitiesCurrent`	$23.27M	USD	Point-in-time
Medical liabilities	`MedicalLiabilitiesCurrent`	$63.97M	USD	Point-in-time
Income taxes payable	`AccruedIncomeTaxesCurrent`	$11.62M	USD	Point-in-time
Income taxes payable	`AccruedIncomeTaxesCurrent`	$12.83M	USD	Point-in-time
Bank loan	`ShortTermBankLoansAndNotesPayable`	-	USD	Point-in-time
Bank loan	`ShortTermBankLoansAndNotesPayable`	$40.26K	USD	Point-in-time
Finance lease obligation	`FinanceLeaseLiabilityCurrent`	$101.74K	USD	Point-in-time
Finance lease obligation	`FinanceLeaseLiabilityCurrent`	$101.74K	USD	Point-in-time
Lease liabilities	`OperatingLeaseLiabilityCurrent`	$2.46M	USD	Point-in-time
Lease liabilities	`OperatingLeaseLiabilityCurrent`	-	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$88.40M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$72.02M	USD	Point-in-time
Lines of credit - related party	`DueToRelatedPartiesNoncurrent`	$13.00M	USD	Point-in-time
Lines of credit - related party	`DueToRelatedPartiesNoncurrent`	$13.00M	USD	Point-in-time
Deferred tax liability	`DeferredTaxLiabilities`	$19.62M	USD	Point-in-time
Deferred tax liability	`DeferredTaxLiabilities`	$16.99M	USD	Point-in-time
Liability for unissued equity shares	`LiabilityForUnissuedEquitySharesNoncurrent`	$1.19M	USD	Point-in-time
Liability for unissued equity shares	`LiabilityForUnissuedEquitySharesNoncurrent`	$1.19M	USD	Point-in-time
Finance lease obligation	`FinanceLeaseLiabilityNoncurrent`	$517.26K	USD	Point-in-time
Finance lease obligation	`FinanceLeaseLiabilityNoncurrent`	$492.11K	USD	Point-in-time
Lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$5.98M	USD	Point-in-time
Lease liabilities	`OperatingLeaseLiabilityNoncurrent`	-	USD	Point-in-time
Total noncurrent liabilities	`LiabilitiesNoncurrent`	$34.32M	USD	Point-in-time
Total noncurrent liabilities	`LiabilitiesNoncurrent`	$37.65M	USD	Point-in-time
Total liabilities	`Liabilities`	$106.34M	USD	Point-in-time
Total liabilities	`Liabilities`	$126.05M	USD	Point-in-time
Commitments and Contingencies (Note 10)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and Contingencies (Note 10)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Noncontrolling interest in Allied Pacific of California IPA ("APC")	`TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests`	$212.43M	USD	Point-in-time
Noncontrolling interest in Allied Pacific of California IPA ("APC")	`TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests`	$225.12M	USD	Point-in-time
Common stock, par value $0.001; 100,000,000 shares authorized, 34,503,704 and 34,578,040 shares outstanding, excluding 1,944,054 and 1,850,603 treasury shares, at March 31, 2019 and December 31, 2018, respectively	`CommonStockValue`	$34.50K	USD	Point-in-time
Common stock, par value $0.001; 100,000,000 shares authorized, 34,503,704 and 34,578,040 shares outstanding, excluding 1,944,054 and 1,850,603 treasury shares, at March 31, 2019 and December 31, 2018, respectively	`CommonStockValue`	$34.58K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$162.72M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$163.01M	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$17.79M	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$17.93M	USD	Point-in-time
Stockholders' deficit attributable to Apollo Medical Holdings, Inc.	`StockholdersEquity`	$180.55M	USD	Point-in-time
Stockholders' deficit attributable to Apollo Medical Holdings, Inc.	`StockholdersEquity`	$180.97M	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$1.41M	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$998.32K	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$164.18M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$181.54M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$170.49M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$182.38M	USD	Point-in-time
Total liabilities, mezzanine equity and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$513.00M	USD	Point-in-time
Total liabilities, mezzanine equity and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$520.86M	USD	Point-in-time

Income Statement 42 line items

Line Item	Tag	Value	Unit	Period
Total revenue	`Revenues`	$123.92M	USD	1 Quarter
Total revenue	`Revenues`	$95.76M	USD	1 Quarter
Cost of services	`CostOfGoodsAndServicesSold`	$83.43M	USD	1 Quarter
Cost of services	`CostOfGoodsAndServicesSold`	$84.61M	USD	1 Quarter
General and administrative expenses	`GeneralAndAdministrativeExpense`	$10.26M	USD	1 Quarter
General and administrative expenses	`GeneralAndAdministrativeExpense`	$11.30M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$5.06M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$4.42M	USD	1 Quarter
Provision for doubtful accounts	`ProvisionForDoubtfulAccounts`	$951.01K	USD	1 Quarter
Provision for doubtful accounts	`ProvisionForDoubtfulAccounts`	$247.10K	USD	1 Quarter
Total expenses	`OperatingExpenses`	$99.07M	USD	1 Quarter
Total expenses	`OperatingExpenses`	$101.22M	USD	1 Quarter
(Loss) income from operations	`OperatingIncomeLoss`	$22.70M	USD	1 Quarter
(Loss) income from operations	`OperatingIncomeLoss`	$-3.31M	USD	1 Quarter
Loss from equity method investments	`IncomeLossFromEquityMethodInvestments`	$-28.02K	USD	1 Quarter
Loss from equity method investments	`IncomeLossFromEquityMethodInvestments`	$-849.66K	USD	1 Quarter
Interest expense	`InterestExpense`	$210.98K	USD	1 Quarter
Interest expense	`InterestExpense`	$85.00K	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$269.82K	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$323.01K	USD	1 Quarter
Other income	`OtherNonoperatingIncomeExpense`	$87.99K	USD	1 Quarter
Other income	`OtherNonoperatingIncomeExpense`	$187.12K	USD	1 Quarter
Total other (expense) income, net	`NonoperatingIncomeExpense`	$244.79K	USD	1 Quarter
Total other (expense) income, net	`NonoperatingIncomeExpense`	$-550.51K	USD	1 Quarter
(Loss) income before (benefit from) provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-3.86M	USD	1 Quarter
(Loss) income before (benefit from) provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$22.95M	USD	1 Quarter
(Benefit from) provision for income taxes	`IncomeTaxExpenseBenefit`	$7.23M	USD	1 Quarter
(Benefit from) provision for income taxes	`IncomeTaxExpenseBenefit`	$-1.41M	USD	1 Quarter
Net (loss) income	`ProfitLoss`	$-2.45M	USD	1 Quarter
Net (loss) income	`ProfitLoss`	$15.72M	USD	1 Quarter
Net (loss) income attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$13.56M	USD	1 Quarter
Net (loss) income attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-2.59M	USD	1 Quarter
Net income attributable to Apollo Medical Holdings, Inc.	`NetIncomeLoss`	$139.66K	USD	1 Quarter
Net income attributable to Apollo Medical Holdings, Inc.	`NetIncomeLoss`	$2.16M	USD	1 Quarter
Earnings per share basic	`EarningsPerShareBasic`	-	USD	1 Quarter
Earnings per share basic	`EarningsPerShareBasic`	$0.07	USD	1 Quarter
Earnings per share diluted	`EarningsPerShareDiluted`	$0.06	USD	1 Quarter
Earnings per share diluted	`EarningsPerShareDiluted`	-	USD	1 Quarter
Weighted average shares of common stock outstanding basic	`WeightedAverageNumberOfSharesOutstandingBasic`	32.42M	shares	1 Quarter
Weighted average shares of common stock outstanding basic	`WeightedAverageNumberOfSharesOutstandingBasic`	34.50M	shares	1 Quarter
Weighted average shares of common stock outstanding diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	38.07M	shares	1 Quarter
Weighted average shares of common stock outstanding diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	38.10M	shares	1 Quarter

Cash Flow Statement 91 line items

Line Item	Tag	Value	Unit	Period
Net (loss) income	`ProfitLoss`	$-2.45M	USD	1 Quarter
Net (loss) income	`ProfitLoss`	$15.72M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$5.06M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$4.42M	USD	1 Quarter
Loss of disposal of property and equipment	`GainLossOnSaleOfPropertyPlantEquipment`	-	USD	1 Quarter
Loss of disposal of property and equipment	`GainLossOnSaleOfPropertyPlantEquipment`	$-41.78K	USD	1 Quarter
Provision for doubtful accounts	`ProvisionForDoubtfulAccounts`	$951.01K	USD	1 Quarter
Provision for doubtful accounts	`ProvisionForDoubtfulAccounts`	$247.10K	USD	1 Quarter
Share-based compensation	`AllocatedShareBasedCompensationExpense`	$833.94K	USD	1 Quarter
Share-based compensation	`AllocatedShareBasedCompensationExpense`	$345.13K	USD	1 Quarter
Unrealized (gain) loss from investment in equity securities	`UnrealizedGainLossOnInvestments`	$7.73K	USD	1 Quarter
Unrealized (gain) loss from investment in equity securities	`UnrealizedGainLossOnInvestments`	$-8.55K	USD	1 Quarter
Loss from equity method investments	`IncomeLossFromEquityMethodInvestments`	$-28.02K	USD	1 Quarter
Loss from equity method investments	`IncomeLossFromEquityMethodInvestments`	$-849.66K	USD	1 Quarter
Deferred tax	`DeferredIncomeTaxExpenseBenefit`	$-2.62M	USD	1 Quarter
Deferred tax	`DeferredIncomeTaxExpenseBenefit`	$2.81M	USD	1 Quarter
Receivable, net	`IncreaseDecreaseInAccountsReceivable`	$-1.30M	USD	1 Quarter
Receivable, net	`IncreaseDecreaseInAccountsReceivable`	$-486.98K	USD	1 Quarter
Receivable, net related parties	`IncreaseDecreaseInDueFromRelatedParties`	$22.63M	USD	1 Quarter
Receivable, net related parties	`IncreaseDecreaseInDueFromRelatedParties`	$7.51M	USD	1 Quarter
Other receivables	`IncreaseDecreaseInOtherReceivables`	$11.24M	USD	1 Quarter
Other receivables	`IncreaseDecreaseInOtherReceivables`	-	USD	1 Quarter
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAssets`	$728.63K	USD	1 Quarter
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAssets`	$-232.39K	USD	1 Quarter
Right-of-use assets	`IncreaseDecreaseInOperatingLeaseAssets`	$447.96K	USD	1 Quarter
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$442.88K	USD	1 Quarter
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$59.44K	USD	1 Quarter
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$22.58M	USD	1 Quarter
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-1.17M	USD	1 Quarter
Incentives payable	`Increasedecreaseinincentivespayable`	$-6.60M	USD	1 Quarter
Incentives payable	`Increasedecreaseinincentivespayable`	-	USD	1 Quarter
Fiduciary accounts payable	`IncreaseDecreaseInOtherAccountsPayable`	$-630.96K	USD	1 Quarter
Fiduciary accounts payable	`IncreaseDecreaseInOtherAccountsPayable`	$546.33K	USD	1 Quarter
Medical liabilities	`IncreaseDecreaseInMedicalLiabilities`	$5.14M	USD	1 Quarter
Medical liabilities	`IncreaseDecreaseInMedicalLiabilities`	$-10.38M	USD	1 Quarter
Income taxes payable	`IncreaseDecreaseInAccruedIncomeTaxesPayable`	$4.42M	USD	1 Quarter
Income taxes payable	`IncreaseDecreaseInAccruedIncomeTaxesPayable`	$1.21M	USD	1 Quarter
Lease liabilities	`IncreaseDecreaseInOtherOperatingOpearatingLeaseLiabilities`	$-416.25K	USD	1 Quarter
Lease liabilities	`IncreaseDecreaseInOtherOperatingOpearatingLeaseLiabilities`	-	USD	1 Quarter
Net cash (used in) provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-3.97M	USD	1 Quarter
Net cash (used in) provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$4.74M	USD	1 Quarter
Purchases of marketable securities	`PaymentsToAcquireMarketableSecurities`	$8.18K	USD	1 Quarter
Purchases of marketable securities	`PaymentsToAcquireMarketableSecurities`	$3.93K	USD	1 Quarter
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$485.12K	USD	1 Quarter
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$103.62K	USD	1 Quarter
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-489.05K	USD	1 Quarter
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-111.79K	USD	1 Quarter
Repayments on bank loan	`RepaymentsOfRelatedPartyDebt`	$40.26K	USD	1 Quarter
Repayments on bank loan	`RepaymentsOfRelatedPartyDebt`	$140.61K	USD	1 Quarter
Dividends paid	`PaymentsOfDividends`	$2.00M	USD	1 Quarter
Dividends paid	`PaymentsOfDividends`	$10.00M	USD	1 Quarter
Payment of capital lease obligations	`RepaymentsOfDebtAndCapitalLeaseObligations`	$24.41K	USD	1 Quarter
Payment of capital lease obligations	`RepaymentsOfDebtAndCapitalLeaseObligations`	$25.15K	USD	1 Quarter
Proceeds from exercise of stock options and warrants	`ProceedsFromWarrantExercises`	$1.92M	USD	1 Quarter
Proceeds from exercise of stock options and warrants	`ProceedsFromWarrantExercises`	$139.97K	USD	1 Quarter
Repurchase of shares	`PaymentsForRepurchaseOfCommonStock`	$40.00K	USD	1 Quarter
Repurchase of shares	`PaymentsForRepurchaseOfCommonStock`	-	USD	1 Quarter
Proceeds from common stock offering	`ProceedsFromIssuanceOfCommonStock`	-	USD	1 Quarter
Proceeds from common stock offering	`ProceedsFromIssuanceOfCommonStock`	$155.00K	USD	1 Quarter
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-9.81M	USD	1 Quarter
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-241.23K	USD	1 Quarter
Net (decrease) increase in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$-13.89M	USD	1 Quarter
Net (decrease) increase in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$4.01M	USD	1 Quarter
Cash, cash equivalents and restricted cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$118.50M	USD	Point-in-time
Cash, cash equivalents and restricted cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$93.75M	USD	Point-in-time
Cash, cash equivalents and restricted cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$107.64M	USD	Point-in-time
Cash, cash equivalents and restricted cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$122.51M	USD	Point-in-time
Cash, cash equivalents and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$118.50M	USD	Point-in-time
Cash, cash equivalents and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$93.75M	USD	Point-in-time
Cash, cash equivalents and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$107.64M	USD	Point-in-time
Cash, cash equivalents and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$122.51M	USD	Point-in-time
Cash paid for income taxes	`IncomeTaxesPaid`	-	USD	1 Quarter
Cash paid for income taxes	`IncomeTaxesPaid`	-	USD	1 Quarter
Cash paid for interest	`InterestPaidNet`	$181.82K	USD	1 Quarter
Cash paid for interest	`InterestPaidNet`	$73.61K	USD	1 Quarter
Cashless exercise of stock options	`CashlessExerciseOfStockOptions`	-	USD	1 Quarter
Cashless exercise of stock options	`CashlessExerciseOfStockOptions`	$-43.00	USD	1 Quarter
Deferred tax liability adjusted to goodwill	`DeferredTaxLiabilityAdjustedToGoodwill`	$914.01K	USD	1 Quarter
Deferred tax liability adjusted to goodwill	`DeferredTaxLiabilityAdjustedToGoodwill`	-	USD	1 Quarter
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$103.73M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$93.01M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$106.89M	USD	Point-in-time
Restricted cash short-term - distributions to former NMM shareholders	`RestrictedCashCurrent`	$18.03M	USD	Point-in-time
Restricted cash short-term - distributions to former NMM shareholders	`RestrictedCashCurrent`	-	USD	Point-in-time
Restricted cash long-term - letters of credit	`RestrictedCashNoncurrent`	$745.29K	USD	Point-in-time
Restricted cash long-term - letters of credit	`RestrictedCashNoncurrent`	$740.21K	USD	Point-in-time
Restricted cash long-term - letters of credit	`RestrictedCashNoncurrent`	$745.47K	USD	Point-in-time
Total cash, cash equivalents, and restricted cash shown in the statement of cash flows	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$118.50M	USD	Point-in-time
Total cash, cash equivalents, and restricted cash shown in the statement of cash flows	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$93.75M	USD	Point-in-time
Total cash, cash equivalents, and restricted cash shown in the statement of cash flows	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$107.64M	USD	Point-in-time
Total cash, cash equivalents, and restricted cash shown in the statement of cash flows	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$122.51M	USD	Point-in-time

Stockholders Equity 18 line items

Line Item	Tag	Value	Unit	Period
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$164.18M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$181.54M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$170.49M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$182.38M	USD	Point-in-time
ASC 606 Adoption	`CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption`	$1.00M	USD	Point-in-time
Net (loss) income	`ProfitLoss`	$-2.45M	USD	1 Quarter
Net (loss) income	`ProfitLoss`	$15.72M	USD	1 Quarter
Purchase of treasury shares	`TreasuryStockValueAcquiredParValueMethod`	-	USD	1 Quarter
Shares issued for exercise of options and warrants	`StockIssuedDuringThePeriodValueOfExerciseOfOptionAndWarrants`	$139.97K	USD	1 Quarter
Shares issued for exercise of options and warrants	`StockIssuedDuringThePeriodValueOfExerciseOfOptionAndWarrants`	$1.92M	USD	1 Quarter
Share-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$142.75K	USD	1 Quarter
Share-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$631.56K	USD	1 Quarter
Dividends	`Dividends`	-	USD	1 Quarter
Dividends	`Dividends`	-	USD	1 Quarter
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$164.18M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$181.54M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$170.49M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$182.38M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.